Occudo Quantitative Strategies LP Has $162,000 Stock Holdings in Varex Imaging Co. (NASDAQ:VREX)

Occudo Quantitative Strategies LP cut its holdings in shares of Varex Imaging Co. (NASDAQ:VREX - Free Report) by 80.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,071 shares of the company's stock after selling 46,834 shares during the quarter. Occudo Quantitative Strategies LP's holdings in Varex Imaging were worth $162,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Aquatic Capital Management LLC bought a new stake in shares of Varex Imaging in the 4th quarter valued at about $25,000. Quadrant Capital Group LLC raised its holdings in shares of Varex Imaging by 115.4% in the 4th quarter. Quadrant Capital Group LLC now owns 2,837 shares of the company's stock valued at $41,000 after purchasing an additional 1,520 shares during the period. KLP Kapitalforvaltning AS bought a new stake in shares of Varex Imaging in the 4th quarter valued at about $98,000. US Bancorp DE raised its holdings in shares of Varex Imaging by 149.8% in the 4th quarter. US Bancorp DE now owns 7,386 shares of the company's stock valued at $108,000 after purchasing an additional 4,429 shares during the period. Finally, New York State Common Retirement Fund raised its holdings in shares of Varex Imaging by 60.7% in the 4th quarter. New York State Common Retirement Fund now owns 9,531 shares of the company's stock valued at $139,000 after purchasing an additional 3,600 shares during the period.

Insiders Place Their Bets

In other Varex Imaging news, SVP Kimberley E. Honeysett sold 4,007 shares of the stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $12.81, for a total transaction of $51,329.67. Following the transaction, the senior vice president now owns 4,002 shares in the company, valued at $51,265.62. This represents a 50.03% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Sunny Sanyal sold 8,749 shares of the stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $11.24, for a total transaction of $98,338.76. Following the transaction, the chief executive officer now owns 190,193 shares in the company, valued at approximately $2,137,769.32. The trade was a 4.40% decrease in their position. The disclosure for this sale can be found here. Company insiders own 4.30% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on VREX. B. Riley raised shares of Varex Imaging to a "strong-buy" rating in a report on Monday, May 12th. Wall Street Zen lowered shares of Varex Imaging from a "strong-buy" rating to a "buy" rating in a research note on Thursday. Finally, Oppenheimer decreased their price target on shares of Varex Imaging from $30.00 to $23.00 and set an "outperform" rating on the stock in a research note on Friday, February 7th.

Varex Imaging Stock Performance

VREX traded down $0.21 on Friday, reaching $7.52. The company had a trading volume of 373,927 shares, compared to its average volume of 576,036. Varex Imaging Co. has a fifty-two week low of $6.76 and a fifty-two week high of $16.93. The stock has a market cap of $309.82 million, a P/E ratio of -6.43 and a beta of 0.62. The company's fifty day moving average is $8.87 and its 200 day moving average is $12.34. The company has a debt-to-equity ratio of 1.02, a quick ratio of 2.50 and a current ratio of 4.36.

Varex Imaging (NASDAQ:VREX - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.26 EPS for the quarter, beating analysts' consensus estimates of $0.14 by $0.12. Varex Imaging had a negative net margin of 5.79% and a positive return on equity of 4.00%. The business had revenue of $212.90 million for the quarter, compared to analyst estimates of $206.76 million. During the same quarter in the prior year, the business earned $0.16 EPS. Varex Imaging's quarterly revenue was up 3.3% on a year-over-year basis. As a group, analysts predict that Varex Imaging Co. will post 0.53 earnings per share for the current fiscal year.

Varex Imaging Company Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.